New CEO, Same Scorecard: CTS Hits Records on Diversification, but Reimbursements Cloud the Lens

A Record Quarter, Headlined by Diversification

CTS Corporation's second-quarter 2026 results, its first under new CEO Pratik Trivedi, were hard to miss: revenue of $145 million grew 7% year over year, adjusted diluted EPS hit a record $0.74, and adjusted gross margin expanded to 41.5%. The story is diversification. sensor portfolio and other diversified end markets now represent 59% of total sales, up from 55% a year ago, and grew 15% in the quarter. Trivedi framed it succinctly: “Our diversified end markets increased 15% year over year and represented 59% of total sales.” — Pratik Trivedi, Chief Executive Officer (CEO) · 2026-07-28 The growth was broad-based across medical, industrial, and a recovering aerospace & defense pipeline.

The Med-Tech Accelerator and Industrial Resilience

Medical was the standout, with revenue up 45% to $28 million, fueled by sensing and actuation in advanced diagnostics and therapeutics. The Defense end markets saw a 15% year-over-year decline, but government funding is beginning to flow, and the book-to-bill ratio of 1.23 signals a stronger second half. Industrial continued its rebound, up 16%, with new business awards in process instrumentation and cryogenic positioning. The pattern is clear: CTS is shifting its mix toward higher-margin, longer-cycle diversified markets, a strategy that was already evident in prior quarters. As CFO Ashish Agrawal noted back in April, "We have pretty good margins on the transportation side as well, but the diversified markets are better." “Within the diversified markets, it is more, I would say, less evenly-it is not as widely spread. So medical is definitely the strongest end market in terms of margin profile.” — Ashish Agrawal, CFO or Finance Executive · 2026-04-29

Transportation: Weak Volumes, but a Record Win

Transportation sales slipped 2% as global light vehicle production remains soft, but the quarter produced an extraordinary jackpot in new business: $163 million in awards, including a record $100 million sensor win with a North American OEM for an integrated wheel-speed accelerometer. Trivedi highlighted the sensor portfolio as "powertrain-agnostic" — a deliberate hedge against EV transition uncertainty. He added, “We are delighted by the scale of our sensors portfolio wins this quarter. Underscoring the strategic importance of our technologies across powertrain agnostic platforms.” — Pratik Trivedi, Chief Executive Officer (CEO) · 2026-07-28 The company also gained a new EV customer for a seat-track position sensor.

The Asterisks: Reimbursements, FX, and R&D Normalization

Not everything in the second quarter was purely organic. CFO Ashish Agrawal disclosed that the quarter included "foreign currency favorability as well as a larger customer reimbursement," which together added roughly $0.07 to adjusted EPS. The keyword reimbursement spiked in this quarter's transcript, and management was careful to frame it as a one-time-ish item. On R&D, Agrawal said, “We do expect the R&D expenses to normalize going forward.” — Ashish Agrawal, Chief Financial Officer (CFO) · 2026-07-28 That suggests the record margin may not repeat at the same level, but the underlying trend toward a higher-quality earnings mix is real. The company's gross margin has been climbing: Gross margin reached 41.5% in Q2, up 270 basis points year over year; the 10-year trend shows a steady rise from ~35%.

Funding, Tariffs, and the Second-Half Outlook

Aerospace & defense has been the laggard, but the company sees a clear catalyst: government funding is finally moving. "While funding deployments have been gradual, we are beginning to see government funding flow into several key programs," Trivedi said. The tariff announcements last week were assessed as having no material impact, though management continues to monitor precious metal and input cost pressures. For the full year, CTS raised guidance to $565–585 million in sales and $2.55–2.70 in adjusted EPS, implying a strong second half. In the prior call, CEO Kieran O'Sullivan had already signaled the improving trend: “We feel like we're on a good steady path of improving trend here.” — Kieran O'Sullivan, CEO · 2026-02-10

The more telling signal may be the company's operational improvements and the continuity of strategy under the new CEO. In a market where many industrials are guiding conservatively, CTS is raising. The fundamental trajectory supports it — Total revenue has risen from ~$99 million in Q2 2016 to $145 million in Q2 2026, with the diversified share now the majority. The key risk is whether the $0.07 eps helpers recur; if not, the second half might look less explosive than the headline suggests. But even ex-items, the record order intake and a 1.1 book-to-bill imply momentum.

Diversification remains a strategic priority to drive growth and margin expansion, and we continue to push our powertrain agnostic solutions in transportation.

For investors, the quarter is a confirmation that CTS's pivot away from cyclical transportation is working. The question now is whether the new CEO can sustain the acceleration — and whether the market, which has pulled back 15% from June highs despite the report, will give credit. The tape shows the stock down 15.5% from its June 22 peak, meaning the good news may already be partially priced, or that investors are focused on the second-half uncertainties. Either way, the fundamental story is improving.